Based on public information; not affiliated with or endorsed by Eli Lilly and Company.
Eli Lilly and Company: public pathways for academic researchers
Checked 30 Oct 2026.
1. What Lilly says publicly
Process chemistry
- Lilly reports co-authoring a manuscript on an alternative synthesis of the C-terminus of tirzepatide using liquid-phase peptide synthesis (LPPS), which it says replaces waste-intensive solid-phase steps and reduces the process mass intensity (PMI) of the peptide production process (published in Organic Process Research & Development).[1]
Continuous manufacturing
- Lilly lists "implementing new manufacturing technologies that minimize environmental impact, including continuous flow processes, which Lilly has helped advance within the pharmaceutical industry".[1]
Sustainable process
- Lilly says it uses "the 12 principles of green chemistry, environmental risk assessments, packaging and manufacturing reviews and an environmental development review process" as products scale from development to manufacturing.[1]
- Lilly says it has replaced several hazardous solvents and hazardous air pollutants with safer alternative solvents in its chemical synthesis operations, and works to reduce waste through lower solvent and water use.[1]
- Lilly says it collaborates with the ACS Pharmaceutical Roundtable and the IQ Consortium's Green Chemistry Working Group, and "currently hold[s] a leadership role within the ACS Pharmaceutical Roundtable".[1]
Not published by the company on the pages we checked: Crystallization, Solid state, Impurities, PAT / digital (checked 30 Oct 2026).
2. Named academic programmes
Lilly Research Award Program (LRAP)
- Gives Lilly scientists working on basic and applied research projects an avenue to partner with external researchers worldwide on collaborative projects.[2]
- "Research proposals must be initiated by Lilly scientists and then prepared jointly by the Lilly scientist sponsoring the project and an external investigator, according to guidelines established by Lilly."[2]
- Proposals are reviewed by a panel of Lilly scientists and prioritised for funding on novelty (including potential impact), expertise of the external investigator, and feasibility.[2]
- Funding decisions, with written feedback, are made available to the internal Lilly sponsor approximately 45 days after each application cycle closes.[2]
- Described as pre-competitive, so Lilly and external researchers can publish results jointly. Contact: LRAP@lilly.com.[2]
Not published by the company on the pages we checked: Award amounts, cycle dates (checked 30 Oct 2026).
3. Memberships in our industry directory
- Enabling Technologies Consortium (ETC): named as “Eli Lilly”.[4]
- Young Institute Pharmaceutical Manufacturing Consortium (Purdue): named as “Eli Lilly and Company”.[5]
- Eli Lilly and Company and Purdue University Research Alliance Center (LPRC): named as “Eli Lilly and Company”.[6]
- PharmaSEL-Prosperity Partnership (Imperial College London / UCL): named as “Eli Lilly and Company”.[7]
- Center for Integrated Material Science and Engineering of Pharmaceutical Products (CIMSEPP), NSF IUCRC: named as “Eli Lilly”.[8]
- CMAC (Continuous Manufacturing and Advanced Crystallisation): named as “Lilly”. Named as a strategic member in Pfizer's release, as announced Dec 2017 (18 Dec 2017).[3]
- ACS Green Chemistry Institute Pharmaceutical Roundtable (GCIPR): named as “ACS Pharmaceutical Roundtable”. Lilly's own page describes a leadership role in the Roundtable.[1]
4. Open or recurring calls on this site
No open or recurring calls from Lilly are on this site right now.
5. Entry points
What the labels mean
- Open to applyA funding programme that eligible researchers can apply to, through the route the official page describes.
- Needs an internal contactA proposal has to start with, or be sponsored by, someone inside the company.
- Via a consortium or centerEngagement runs through a consortium or centre that names the company; see its card on /industry/.
- Members onlyOnly paying or member organisations take part.
- Partnering enquiry (not a funding call)A route to contact the company about a collaboration; it is not a funding programme.
- Needs an internal contactLilly Research Award Program (LRAP): Proposals must be initiated by a Lilly scientist and prepared jointly with the external investigator.[2]
- Via a consortium or centerConsortia and centres that name Lilly: See the memberships above; how outsiders take part differs by centre (each card on /industry/ gives its route).[memberships]
6. Sources
- Product Stewardship & Green Chemistry (Lilly sustainability site) · https://sustainability.lilly.com/impactareas/product-stewardship · checked 30 Oct 2026 (by hand; the site does not allow automated checks)
- Lilly Research Award Program (LRAP) · https://www.lilly.com/science/partners/research-award-program · checked 30 Oct 2026 (by hand; the site does not allow automated checks)
- CMAC Medicines Manufacturing Consortium Welcomes Pfizer as Newest Partner (Pfizer press release, 18 Dec 2017) · https://www.pfizer.com/news/press-release/press-release-detail/cmac-medicines-manufacturing-consortium-welcomes-pfizer · checked 30 Oct 2026 (by hand; the site does not allow automated checks)
- Enabling Technologies Consortium (ETC): ETC Members · https://etconsortium.org/about-us/ · checked 30 Oct 2026
- Young Institute Pharmaceutical Manufacturing Consortium (Purdue): Named as consortium collaborators · https://younginstitute.research.purdue.edu/research/ · checked 30 Oct 2026
- Eli Lilly and Company and Purdue University Research Alliance Center (LPRC): Named in the centre's title · https://younginstitute.research.purdue.edu/research/ · checked 30 Oct 2026
- PharmaSEL-Prosperity Partnership (Imperial College London / UCL): Named on the programme page · https://www.imperial.ac.uk/pharmasel/ · checked 30 Oct 2026
- Center for Integrated Material Science and Engineering of Pharmaceutical Products (CIMSEPP), NSF IUCRC: Member organizations (as submitted by the Center to NSF) · https://iucrc.nsf.gov/centers/center-for-integrated-material-science-and-engineering-of-pharmaceutical-products-cimsepp/ · checked 30 Oct 2026